Home
>
National Drug Code (NDC)
>
RISPERDAL
RISPERDAL - 50458-301-04 - (risperidone)
Drug Information of RISPERDAL
| Product NDC: | 50458-301 |
| Proprietary Name: | RISPERDAL |
| Non Proprietary Name: | risperidone |
| Active Ingredient(s): | .25 mg/1 & nbsp; risperidone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of RISPERDAL
| Product NDC: | 50458-301 |
| Labeler Name: | Janssen Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020272 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19931229 |
Package Information of RISPERDAL
| Package NDC: | 50458-301-04 |
| Package Description: | 60 TABLET in 1 BOTTLE (50458-301-04) |
NDC Information of RISPERDAL
| NDC Code | 50458-301-04 |
| Proprietary Name | RISPERDAL |
| Package Description | 60 TABLET in 1 BOTTLE (50458-301-04) |
| Product NDC | 50458-301 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | risperidone |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19931229 |
| Marketing Category Name | NDA |
| Labeler Name | Janssen Pharmaceuticals, Inc. |
| Substance Name | RISPERIDONE |
| Strength Number | .25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |
